Cardiac Safety Services - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511241801

Publication Date:

November 11, 2024

Pages:

129

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Cardiac safety services can be defined as services that deal with supporting and designing clinical trials and other studies required for the monitoring of cardiac safety.Cardiac safety services are focused on monitoring the entire cardiac safety profile across various phases of clinical trials, including Phase I to Phase IV. These studies are done in compliance with FDA, PMDA, EMA, and other regulatory bodies.Cardiovascular safety assessment services include non-invasive cardiac imaging, physiologic stress testing, platelet aggregation, ambulatory blood pressure monitoring, and other services, along with the QT studies.Integrated services offering cardiac safety services are mostly preferred owing to the bundling of services with focus on end-to-end development, as compared to the specificity of standalone services
The global market for Cardiac Safety Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Cardiac Safety Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cardiac Safety Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Cardiac Safety Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Cardiac Safety Services include Biotrial, Banook Group, Bioclinica, Certara L.P., Celerion, Inc, ERT, Inc, Laboratory Corporation of America Holdings, Medpace Holdings, Inc. and Ncardia AG, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cardiac Safety Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cardiac Safety Services by region & country, by Type, and by Application.
The Cardiac Safety Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Safety Services.
麻豆原创 Segmentation
By Company
Biotrial
Banook Group
Bioclinica
Certara L.P.
Celerion, Inc
ERT, Inc
Laboratory Corporation of America Holdings
Medpace Holdings, Inc.
Ncardia AG
Richmond Pharmacology
PhysioStim
IQVIA
BioTelemetry, Inc
Pharmaceutical Product Development, LLC
Shanghai Medicilon Inc
SGS SA
Spaulding Clinical Research, LLC
Segment by Type:
by Type
Integrated Services
Standalone Services
by Service Type
Cardiovascular Imaging
Thorough QT studies
Blood Pressure Measurement
ECG Measurement
Others
Segment by Application
Pharmaceutical and Biopharmaceuticals Companies
Contract Research Organization(CRO)
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cardiac Safety Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cardiac Safety Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cardiac Safety Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Cardiac Safety Services Product Introduction
1.2 Global Cardiac Safety Services 麻豆原创 Size Forecast
1.3 Cardiac Safety Services 麻豆原创 Trends & Drivers
1.3.1 Cardiac Safety Services Industry Trends
1.3.2 Cardiac Safety Services 麻豆原创 Drivers & Opportunity
1.3.3 Cardiac Safety Services 麻豆原创 Challenges
1.3.4 Cardiac Safety Services 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cardiac Safety Services Players Revenue Ranking (2023)
2.2 Global Cardiac Safety Services Revenue by Company (2019-2024)
2.3 Key Companies Cardiac Safety Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cardiac Safety Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Cardiac Safety Services
2.6 Cardiac Safety Services 麻豆原创 Competitive Analysis
2.6.1 Cardiac Safety Services 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cardiac Safety Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Safety Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Integrated Services
3.1.2 Standalone Services
3.2 Global Cardiac Safety Services Sales Value by Type
3.2.1 Global Cardiac Safety Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cardiac Safety Services Sales Value, by Type (2019-2030)
3.2.3 Global Cardiac Safety Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical and Biopharmaceuticals Companies
4.1.2 Contract Research Organization(CRO)
4.1.3 Others
4.2 Global Cardiac Safety Services Sales Value by Application
4.2.1 Global Cardiac Safety Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cardiac Safety Services Sales Value, by Application (2019-2030)
4.2.3 Global Cardiac Safety Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cardiac Safety Services Sales Value by Region
5.1.1 Global Cardiac Safety Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cardiac Safety Services Sales Value by Region (2019-2024)
5.1.3 Global Cardiac Safety Services Sales Value by Region (2025-2030)
5.1.4 Global Cardiac Safety Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cardiac Safety Services Sales Value, 2019-2030
5.2.2 North America Cardiac Safety Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cardiac Safety Services Sales Value, 2019-2030
5.3.2 Europe Cardiac Safety Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cardiac Safety Services Sales Value, 2019-2030
5.4.2 Asia Pacific Cardiac Safety Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cardiac Safety Services Sales Value, 2019-2030
5.5.2 South America Cardiac Safety Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cardiac Safety Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Cardiac Safety Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cardiac Safety Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cardiac Safety Services Sales Value
6.3 United States
6.3.1 United States Cardiac Safety Services Sales Value, 2019-2030
6.3.2 United States Cardiac Safety Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cardiac Safety Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cardiac Safety Services Sales Value, 2019-2030
6.4.2 Europe Cardiac Safety Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cardiac Safety Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cardiac Safety Services Sales Value, 2019-2030
6.5.2 China Cardiac Safety Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cardiac Safety Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cardiac Safety Services Sales Value, 2019-2030
6.6.2 Japan Cardiac Safety Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cardiac Safety Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cardiac Safety Services Sales Value, 2019-2030
6.7.2 South Korea Cardiac Safety Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cardiac Safety Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cardiac Safety Services Sales Value, 2019-2030
6.8.2 Southeast Asia Cardiac Safety Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cardiac Safety Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cardiac Safety Services Sales Value, 2019-2030
6.9.2 India Cardiac Safety Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cardiac Safety Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Biotrial
7.1.1 Biotrial Profile
7.1.2 Biotrial Main Business
7.1.3 Biotrial Cardiac Safety Services Products, Services and Solutions
7.1.4 Biotrial Cardiac Safety Services Revenue (US$ Million) & (2019-2024)
7.1.5 Biotrial Recent Developments
7.2 Banook Group
7.2.1 Banook Group Profile
7.2.2 Banook Group Main Business
7.2.3 Banook Group Cardiac Safety Services Products, Services and Solutions
7.2.4 Banook Group Cardiac Safety Services Revenue (US$ Million) & (2019-2024)
7.2.5 Banook Group Recent Developments
7.3 Bioclinica
7.3.1 Bioclinica Profile
7.3.2 Bioclinica Main Business
7.3.3 Bioclinica Cardiac Safety Services Products, Services and Solutions
7.3.4 Bioclinica Cardiac Safety Services Revenue (US$ Million) & (2019-2024)
7.3.5 Certara L.P. Recent Developments
7.4 Certara L.P.
7.4.1 Certara L.P. Profile
7.4.2 Certara L.P. Main Business
7.4.3 Certara L.P. Cardiac Safety Services Products, Services and Solutions
7.4.4 Certara L.P. Cardiac Safety Services Revenue (US$ Million) & (2019-2024)
7.4.5 Certara L.P. Recent Developments
7.5 Celerion, Inc
7.5.1 Celerion, Inc Profile
7.5.2 Celerion, Inc Main Business
7.5.3 Celerion, Inc Cardiac Safety Services Products, Services and Solutions
7.5.4 Celerion, Inc Cardiac Safety Services Revenue (US$ Million) & (2019-2024)
7.5.5 Celerion, Inc Recent Developments
7.6 ERT, Inc
7.6.1 ERT, Inc Profile
7.6.2 ERT, Inc Main Business
7.6.3 ERT, Inc Cardiac Safety Services Products, Services and Solutions
7.6.4 ERT, Inc Cardiac Safety Services Revenue (US$ Million) & (2019-2024)
7.6.5 ERT, Inc Recent Developments
7.7 Laboratory Corporation of America Holdings
7.7.1 Laboratory Corporation of America Holdings Profile
7.7.2 Laboratory Corporation of America Holdings Main Business
7.7.3 Laboratory Corporation of America Holdings Cardiac Safety Services Products, Services and Solutions
7.7.4 Laboratory Corporation of America Holdings Cardiac Safety Services Revenue (US$ Million) & (2019-2024)
7.7.5 Laboratory Corporation of America Holdings Recent Developments
7.8 Medpace Holdings, Inc.
7.8.1 Medpace Holdings, Inc. Profile
7.8.2 Medpace Holdings, Inc. Main Business
7.8.3 Medpace Holdings, Inc. Cardiac Safety Services Products, Services and Solutions
7.8.4 Medpace Holdings, Inc. Cardiac Safety Services Revenue (US$ Million) & (2019-2024)
7.8.5 Medpace Holdings, Inc. Recent Developments
7.9 Ncardia AG
7.9.1 Ncardia AG Profile
7.9.2 Ncardia AG Main Business
7.9.3 Ncardia AG Cardiac Safety Services Products, Services and Solutions
7.9.4 Ncardia AG Cardiac Safety Services Revenue (US$ Million) & (2019-2024)
7.9.5 Ncardia AG Recent Developments
7.10 Richmond Pharmacology
7.10.1 Richmond Pharmacology Profile
7.10.2 Richmond Pharmacology Main Business
7.10.3 Richmond Pharmacology Cardiac Safety Services Products, Services and Solutions
7.10.4 Richmond Pharmacology Cardiac Safety Services Revenue (US$ Million) & (2019-2024)
7.10.5 Richmond Pharmacology Recent Developments
7.11 PhysioStim
7.11.1 PhysioStim Profile
7.11.2 PhysioStim Main Business
7.11.3 PhysioStim Cardiac Safety Services Products, Services and Solutions
7.11.4 PhysioStim Cardiac Safety Services Revenue (US$ Million) & (2019-2024)
7.11.5 PhysioStim Recent Developments
7.12 IQVIA
7.12.1 IQVIA Profile
7.12.2 IQVIA Main Business
7.12.3 IQVIA Cardiac Safety Services Products, Services and Solutions
7.12.4 IQVIA Cardiac Safety Services Revenue (US$ Million) & (2019-2024)
7.12.5 IQVIA Recent Developments
7.13 BioTelemetry, Inc
7.13.1 BioTelemetry, Inc Profile
7.13.2 BioTelemetry, Inc Main Business
7.13.3 BioTelemetry, Inc Cardiac Safety Services Products, Services and Solutions
7.13.4 BioTelemetry, Inc Cardiac Safety Services Revenue (US$ Million) & (2019-2024)
7.13.5 BioTelemetry, Inc Recent Developments
7.14 Pharmaceutical Product Development, LLC
7.14.1 Pharmaceutical Product Development, LLC Profile
7.14.2 Pharmaceutical Product Development, LLC Main Business
7.14.3 Pharmaceutical Product Development, LLC Cardiac Safety Services Products, Services and Solutions
7.14.4 Pharmaceutical Product Development, LLC Cardiac Safety Services Revenue (US$ Million) & (2019-2024)
7.14.5 Pharmaceutical Product Development, LLC Recent Developments
7.15 Shanghai Medicilon Inc
7.15.1 Shanghai Medicilon Inc Profile
7.15.2 Shanghai Medicilon Inc Main Business
7.15.3 Shanghai Medicilon Inc Cardiac Safety Services Products, Services and Solutions
7.15.4 Shanghai Medicilon Inc Cardiac Safety Services Revenue (US$ Million) & (2019-2024)
7.15.5 Shanghai Medicilon Inc Recent Developments
7.16 SGS SA
7.16.1 SGS SA Profile
7.16.2 SGS SA Main Business
7.16.3 SGS SA Cardiac Safety Services Products, Services and Solutions
7.16.4 SGS SA Cardiac Safety Services Revenue (US$ Million) & (2019-2024)
7.16.5 SGS SA Recent Developments
7.17 Spaulding Clinical Research, LLC
7.17.1 Spaulding Clinical Research, LLC Profile
7.17.2 Spaulding Clinical Research, LLC Main Business
7.17.3 Spaulding Clinical Research, LLC Cardiac Safety Services Products, Services and Solutions
7.17.4 Spaulding Clinical Research, LLC Cardiac Safety Services Revenue (US$ Million) & (2019-2024)
7.17.5 Spaulding Clinical Research, LLC Recent Developments
8 Industry Chain Analysis
8.1 Cardiac Safety Services Industrial Chain
8.2 Cardiac Safety Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cardiac Safety Services Sales Model
8.5.2 Sales Channel
8.5.3 Cardiac Safety Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Biotrial
Banook Group
Bioclinica
Certara L.P.
Celerion, Inc
ERT, Inc
Laboratory Corporation of America Holdings
Medpace Holdings, Inc.
Ncardia AG
Richmond Pharmacology
PhysioStim
IQVIA
BioTelemetry, Inc
Pharmaceutical Product Development, LLC
Shanghai Medicilon Inc
SGS SA
Spaulding Clinical Research, LLC

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.